79 related articles for article (PubMed ID: 29061995)
1. Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma.
Gao X; Sheng Y; Yang J; Wang C; Zhang R; Zhu Y; Zhang Z; Zhang K; Yan S; Sun H; Wei J; Wang X; Yu X; Zhang Y; Luo Q; Zheng Y; Qiao P; Zhao Y; Dong Q; Qin L
J Exp Clin Cancer Res; 2018 Jul; 37(1):179. PubMed ID: 30064482
[TBL] [Abstract][Full Text] [Related]
2. Tonicity-responsive enhancer-binding protein promotes stemness of liver cancer and cisplatin resistance.
Lee JH; Suh JH; Kang HJ; Choi SY; Jung SW; Lee-Kwon W; Park SA; Kim H; Ye BJ; Yoo EJ; Jeong GW; Park NH; Kwon HM
EBioMedicine; 2020 Aug; 58():102926. PubMed ID: 32739873
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma.
Yoo BK; Emdad L; Gredler R; Fuller C; Dumur CI; Jones KH; Jackson-Cook C; Su ZZ; Chen D; Saxena UH; Hansen U; Fisher PB; Sarkar D
Proc Natl Acad Sci U S A; 2010 May; 107(18):8357-62. PubMed ID: 20404171
[TBL] [Abstract][Full Text] [Related]
4. RAB5A effect on metastasis of hepatocellular carcinoma cell line via altering the pro-invasive content of exosomes.
Gorji-Bahri G; Moghimi HR; Hashemi A
Exp Mol Pathol; 2021 Jun; 120():104632. PubMed ID: 33831402
[TBL] [Abstract][Full Text] [Related]
5. Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma.
Yang B; Li M; Tang W; Liu W; Zhang S; Chen L; Xia J
Nat Commun; 2018 Feb; 9(1):678. PubMed ID: 29445139
[TBL] [Abstract][Full Text] [Related]
6. c-Met activation through a novel pathway involving osteopontin mediates oncogenesis by the transcription factor LSF.
Yoo BK; Gredler R; Chen D; Santhekadur PK; Fisher PB; Sarkar D
J Hepatol; 2011 Dec; 55(6):1317-24. PubMed ID: 21703197
[TBL] [Abstract][Full Text] [Related]
7. METTL3/16-mediated m
Wei H; Li W; Yang M; Fang Q; Nian J; Huang Y; Wei Q; Huang Z; Liu G; Xu Z; Hu A; Pu J
Clin Immunol; 2024 Apr; 261():109924. PubMed ID: 38310994
[TBL] [Abstract][Full Text] [Related]
8. CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?
Jia Q; Dong Q; Qin L
Oncotarget; 2016 Jan; 7(2):1203-14. PubMed ID: 26497214
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factor VII and malignant progression of hepatocellular carcinoma.
Chen KD; Huang KT; Tsai MC; Wu CH; Kuo IY; Chen LY; Hu TH; Chen CL; Lin CC
Cell Death Dis; 2016 Feb; 7(2):e2110. PubMed ID: 26913602
[No Abstract] [Full Text] [Related]
10. CCN3 promotes epithelial-mesenchymal transition in prostate cancer via FAK/Akt/HIF-1α-induced twist expression.
Chen PC; Tai HC; Lin TH; Wang SW; Lin CY; Chao CC; Yu HJ; Tsai YC; Lai YW; Lin CW; Tang CH
Oncotarget; 2017 Sep; 8(43):74506-74518. PubMed ID: 29088803
[TBL] [Abstract][Full Text] [Related]
11. The advance of CCN3 in fibrosis.
Yin H; Liu N; Zhou X; Chen J; Duan L
J Cell Commun Signal; 2023 Dec; 17(4):1219-1227. PubMed ID: 37378812
[TBL] [Abstract][Full Text] [Related]
12. CCN3/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer.
Son S; Kim H; Lim H; Lee JH; Lee KM; Shin I
Cell Death Dis; 2023 Feb; 14(2):81. PubMed ID: 36737605
[TBL] [Abstract][Full Text] [Related]
13.
Wang Z; Ge X; Shi J; Lu B; Zhang X; Huang J
Oxid Med Cell Longev; 2022; 2022():6711085. PubMed ID: 36062185
[TBL] [Abstract][Full Text] [Related]
14. The CCN axis in cancer development and progression.
Yeger H; Perbal B
J Cell Commun Signal; 2021 Dec; 15(4):491-517. PubMed ID: 33877533
[TBL] [Abstract][Full Text] [Related]
15. CCN Family Proteins in Cancer: Insight Into Their Structures and Coordination Role in Tumor Microenvironment.
Jia Q; Xu B; Zhang Y; Ali A; Liao X
Front Genet; 2021; 12():649387. PubMed ID: 33833779
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Liver Cancer Stem Cells: Non-coding RNAs, Oncogenes and Oncoproteins.
Li J; Zhu Y
Front Cell Dev Biol; 2020; 8():548335. PubMed ID: 33117795
[TBL] [Abstract][Full Text] [Related]
17. Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.
Li W; Liao X; Ning P; Cao Y; Zhang M; Bu Y; Lv J; Jia Q
BMC Cancer; 2019 Apr; 19(1):395. PubMed ID: 31029128
[TBL] [Abstract][Full Text] [Related]
18. CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma.
Jia Q; Xue T; Zhang Q; Cheng W; Zhang C; Ma J; Bu Y; Yu S; Liu Q
Sci Rep; 2017 Oct; 7(1):13846. PubMed ID: 29061995
[TBL] [Abstract][Full Text] [Related]
19. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
